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Abstract: Monoclonal antibodies against Mycobacterium avium subspecies paratuberculosis (Map)
proteins are important tools in Johne’s disease research and diagnostics. Johne’s disease is a chronic
inflammatory intestinal disease of cattle, sheep, and other ruminant animals. We have previously
generated multiple sets of monoclonal antibodies (mAbs) in different studies; however, because
many were generated and screened against a whole-cell extract of Map, the antigens that bind to
these antibodies remained unknown. In this study, we used three different approaches to identify the
corresponding Map antigens for 14 mAbs that could not be identified previously. In the first approach,
a new Map-lambda phage expression library was screened to identify corresponding antigens for
11 mAbs. This approach revealed that mAbs 7C8, 9H3, 12E4, 3G5, and 11B8 all detect MAP_3404
encoding the biotin carboxylase subunit of acetyl-CoA carboxylase, while mAbs 7A6, 11F8, and 10C12
detect the GroEL2 chaperonin (MAP_3936), 6C9 detects electron transfer flavoprotein (MAP_3060c),
and 14G11 detects MAP_3976, a lipoprotein anchoring transpeptidase. The epitopes to a selection of
these mAbs were also defined. In a second approach, MAP_2698c bound monoclonal antibody (mAb)
14D4 as determined using protein arrays. When both of these approaches failed to identify the antigen
for mAb 12C9, immunoprecipitation, mass spectrometry analysis, and codon optimization was used
to identify the membrane protein, MAP_4145, as the reacting antigen. Characterized antibodies
were used to quickly interrogate mycobacterial proteomic preps. We conclude by providing a
complete catalog of available mAbs to Map proteins, along with their cognate antigens and epitopes,
if known. These antibodies are now thoroughly characterized and more useful for research and
diagnostic purposes.
Keywords: Johne’s disease; Mycobacterium avium subspecies paratuberculosis; monoclonal antibodies;
proteomics
1. Introduction
Monoclonal antibodies (mAbs) are important detection reagents for diagnostics and therapeutic
purposes. One exciting and recent application of mAb technology to combat bacterial infection
showed that mice colonized with Klebsiella in the gut and treated with mAbs can be protected against
antibiotic-induced dissemination from the gut [1]. This suggests potential new therapeutic strategies
for the systemic treatment with monoclonal antibodies against gut-colonizing bacteria, of which
Mycobacterium avium subspecies paratuberculosis (Map) is a member. However, very few monoclonal
antibodies have been produced against Map and even less have been characterized. For example,
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two monoclonal antibodies have recently been used to capture Map when coated onto magnetic beads;
however, the Map protein these antibodies bind to remains unknown [2]. The same antigen anonymity
is true for mAbs that react to secreted proteins of Map [3].
To close a research gap and facilitate detection of Map, which causes a chronic intestinal disease in
cattle, sheep, and goats, we previously generated a set of stable hybridomas against Map whole cell
extracts or membrane enriched extracts [4,5]. In those studies, only five antigens were successfully
identified when screening a phage lambda expression library with the antibodies. The DnaK chaperone
(MAP_3840) was identified as the corresponding antigen for mAbs 11G4 and 13A4, along with isocitrate
lyase enzyme (MAP_1643) for mAbs 9G10 and 11F6 [4]. A proline-rich antigen (MAP_1025) was later
identified using a similar screening approach with mAb 17A12 [5]. However, the remaining five mAbs
failed to react with plaques in the phage library and thus their cognate antigens remained unknown.
One of these antibodies (4B6) detected a highly conserved protein among all tested mycobacterial
species [4]. Because of this lack of specificity, mAb 4B6 was not pursued further. A subsequent study
generated 22 additional mAbs in our laboratory that were not published and corresponding antigens
were never identified. Those mAbs were examined further in this study.
In separate studies, our group also obtained mAbs to select proteins of interest using well-defined
recombinant proteins as the immunizing antigen in mice. For example, two mAbs were obtained
when immunizing mice with MAP_1272c, a strong antigen that has been shown to hydrolyze
peptidoglycan [6,7]. This antigen is a NlpC/P60 domain containing protein that was recently
crystalized and shown to have lost the ability to cleave peptidoglycan due to a single amino acid
modification in the catalytic triad [7]. The two mAbs successfully developed to this protein each
bound distinct epitopes in MAP_1272c [6]. Another two mAbs were obtained when immunizing mice
with the 35-kDa major membrane protein [8]. In each study, there was no need to define the cognate
antigen, because the recombinant proteins used for immunizing mice were well characterized [7,9].
However, in several other attempts, mAbs were not successfully obtained with recombinant proteins,
or more commonly, the resulting hybridoma secreting antibodies only reacted to the E. coli expressed
recombinant and not the native Map protein, highlighting the limitation of this approach.
Although we had success identifying cognate antigens by screening a phage expression library
of Map K-10 for several monoclonal antibodies, there were still a number of antibodies that did not
show reactivity using this type of screening method. This result was reproducible even after three
independent attempts at different times with different personnel. Use of antibodies that bind to
unknown antigens in studies can lead to error-prone conclusions. For example, a PD4 mAb was
used in cancer research because it specifically bound to tumor cells. The antibody was obtained by
immunizing mice with the human gastric cell line MGC803 [10]. However, it was later discovered after
a failed cDNA expression library screen that the antigen to PD4 was a membrane protein of Mycoplasma
hyorhinis that could bind directly to tumor cells [11]. Therefore, when library screening approaches
failed, we pursued immunoprecipitation and protein array approaches to identify remaining antigens.
We conclude this study by using the newly acquired information to determine relative abundance
of selected proteins among the Mycobacterium avium complex (MAC) as an example of how these
reagents can quickly interrogate the quality of proteomic preparations. This catalog of monoclonal
antibodies should prove useful for Map research.
2. Materials and Methods
2.1. Map Culture and Whole Cell Extract Preparation
Map bovine strain K-10 and ovine strain S397 were cultured in Middlebrooks 7H9 medium (Becton
Dickinson, Franklin Lakes, NJ, USA) and supplemented with 2 mg of mycobactin J (Allied Monitor Inc.,
Fayette, MO, USA) per liter and 10% oleic acid-albumin-dextrose complex (OADC; Becton Dickinson)
plus 0.05% Tween 80 (Sigma-Aldrich, St. Louis, MO, USA) as described previously [12]. The S397
strain was used in construction of the genomic expression library and the K-10 strain was used for
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whole cell antigen in this study. Antigen preparations were harvested by centrifugation, washed in
phosphate buffered saline (PBS; 10 mM PO4, 137 mM NaCl, and 2.7 mM KCl, pH 7.4.), and sonic
disrupted as described by Waters et al. [12].
2.2. Map-Lambda ZAP Expression Library Construction and Screening
The Map 397 expression library was prepared and used as previously described for the
Map ATCC19698 library [13]. Briefly, DNA from the ovine S397 strain of Map was restriction
digested using Sau3AI (New England Biolabs, Beverly, MA, USA) and fragments in the 4 to 6
kilobase size range were selected for cloning into BamHI predigested lambda ZAP arms (Stratagene,
La Jolla, CA, USA). E. coli XL1-Blue MRF’ was used as the host strain for infection with the
lambda ZAP phage vector. Pilot and scale up platings were conducted on NZY agar plates
(3% [wt·vol−1] N-Z Amine A (Sigma-Aldrich), 1% [wt·vol−1] yeast extract [Fisher Scientific],
pH 7.5), and supplemented as necessary with either 1.5% or 0.7% (wt·vol−1) agarose (Lonza,
Allendale, NJ, USA). Each plate also contained Isopropyl-Beta-D-Thiogalactoside (IPTG; 0.01 M)
and 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal; Sigma-Aldrich), which demonstrated
greater than 85% of the plaques contained inserts. Nitrocellulose plaque lifts were created from each
plate and exposed to mAbs that were mixed equally (10 µg/mL) and diluted 1:200 in a blocking buffer
consisting of PBS with 2% bovine serum albumin (BSA) and 0.1% tween 20 (Sigma). Plaques reacting
with mAbs were subcloned by infection of E. coli XLOLR strain (Stratagene) with the phage lysate
obtained from the positive plaque and the addition of ExAssist helper phage (Stratagene). This infection
resulted in the in-vivo excision of pBK-CMV phagemid containing Map genes of interest. The excision
subclones were selected on NZY agar (1.0% NZ amine, 0.5% NaCl, 0.5% yeast extract, 1.5% agar) with
kanamycin at 50 µg/mL and were numbered consecutively (i.e., phage clone #1, #2, #3, etc).
2.3. Cloning and Expression of Selected Map Open Reading Frames
Most of the recombinant proteins in this study were obtained from an established collection of Map
ORF expression clones in our laboratory [14]. MAP_4145 was not among this collection, but attempts to
amplify the GC-rich coding sequence from strain K-10 using either dimethyl sulfoxide (Sigma-Aldrich),
GC advantage-2 (Clonetech, Mountainview, CA, USA), or Econo-Taq Plus GREEN PCR master
mix (Lucigen, Middleton, WI, USA) for cloning and expression all failed. However, the gene was
ultimately codon optimized for E. coli and chemically synthesized as dsDNA gBlocks (Integrated
DNA Technologies, Coralville, IA, USA) with 30 base-pair complimentary terminal sequences to the
linearized NdeI-XhoI (FastDigest; Thermo Scientific, Minneapolis, MN, USA) pET30a vector for cloning
via the isothermal assembly method [15]. To each isothermal assembly reaction, 25 femtomoles of each
gBlock was added to 75 femtomoles of linearized vector and incubated at 50 ◦C for 1 h. One tenth of
each reaction was transformed into chemically competent E. coli DH5-α host cells and recombinant
clones selected for on LB solid agar medium (BD Difco, Franklin Lakes, NJ, USA), supplemented
with 50 µg/mL kanamycin (Sigma-Aldrich). All cloned inserts were confirmed by DNA sequencing.
Confirmed clones were expressed and recombinant proteins were purified as previously described [16].
Cloned inserts were aligned to the full-length proteins using MacVector version 16.0.8 (MacVector,
Raleigh, NC, USA).
2.4. Immunoblot and Dot Blot Analysis
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot
analysis were conducted using standard methods as previously described [12]. Protein size standards
used in this study were from two commercial suppliers (Thermo Fisher and Bio-Rad). The dot blot assay
was performed using a Bio-Dot 96-well manifold assembly (Bio-Rad, Hercules, CA, USA) following
manufacturer instructions. A range from 0.5 to 1 g of each protein was spotted onto nitrocellulose
sheets using methods previously described [17]. The monoclonal antibodies were diluted anywhere
from 1:50 to 1:1000, depending on high or low secreting hybridomas that produce the mAb.
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The dot blot of full-length proteins was constructed from available recombinant proteins in
our laboratory [14]. Pools of 2, 3, or 4 recombinant proteins were combined in each spot with spot
assignments shown in supplemental Table S1. Dot blots of overlapping peptides representing specific
proteins in this study were treated similarly except that distilled water, instead of PBS, was used as
the diluent. The anti-mouse-HRP (Thermo Scientific) was diluted 1:20,000. Nitrocellulose blots were
developed with Super signal (Thermo Fisher) and exposed Biomax MR film (Carestream Health, Inc.,
Rochester, NY, USA). Exposed film was processed using a PROTEC EcoMAX X-ray film processor
(Oberstenfeld, Germany). For the quantitative dot blot experiments, mycobacterial sonicated protein
extracts were initially quantitated using the Lowery protein assay (Thermo Scientific). Equivalent
amounts of extract from each strain were diluted and loaded onto nitrocellulose sheets using the
Bio-Dot 96-well manifold assembly.
2.5. ELISA Assay
A homemade ELISA was conducted for mycobacterial reactivity studies and epitope mapping
studies. Briefly, peptides were all reconstituted at 1.0 to 1.5 mg/mL concentrations in sterile DNase-free
distilled water and stored, as described in Section 2.7. Nunc polysorb 96-well plates were coated with
1 µg of each peptide or mycobacterial extract per well in coating buffer (0.05 M carbonate-bicarbonate
buffer, pH 9.6) overnight at 4 ◦C. Sequence and location for the peptide arrays are listed in the
supplemental Table S2. Plates were washed three times in PBS-0.05% tween 20 and blocked at
room temperature for 1 h in 1% BSA-PBS-0.05%, tween 20. Next, three washes were performed as
above and monoclonal antibodies were diluted in 1% BSA-PBS-0.05% tween 20 and added to the
plate (100 µL/well) for 1 h at room temperature. Three washes were again performed as above and
anti-mouse-HRP (Thermo Fisher) was diluted 1:20,000, added to each well and incubated for 1 h.
A final three washes were performed and SureBlue TMB-1 substrate (KPL, Gaithersburg, MD, USA)
was added for 5–10 min. The reaction was stopped in TMB stop solution (KPL) and plates were read at
450 nm in a SpectrMax340 spectrometer (Molecular Devices, San Jose, CA, USA).
2.6. Antigen Capture and Mass Spectroscopy
The Map protein that binds to mAb 12C9 was captured by an indirect and direct
immunoprecipitation. The Map K-10 extract was biochemically fractionated and each fraction was
examined for the presence of the antigen. The fraction with the strongest reactivity to 12C9 was
used in the immunoprecipitation experiment. To isolate the 12C9-antigen complex via the indirect
method, 500 µg of extract was mixed with 0.8 µg 12C9 antibody in 1× PBS buffer for 1 h followed
by addition of magnetic sheep anti-mouse IgG Dynabeads (Novex/Life Technologies) for 30 min at
room temperature. To induce release of antigen from the 12C9-bead complex, the beads were washed
2 times in 1× PBS and then boiled in 2× SDS loading buffer for 5 min and subjected to SDS-PAGE
and GelCode Blue staining. Sections were excised from the polyacrylamide and processed for mass
spectrometry. The direct capture method was similar to above except that the antibody was exposed to
the Dynabeads for 30 min prior to a 1-h incubation with the extract.
The excised gel slices were trypsin digested, dried, and analyzed on a nano-LC chromatography
using a Proxeon Easy-nLC connected to LTQ OrbiTrap Velos Pro mass spectrometer (ThermoFisher
Scientific, West Palm Beach, FL, USA) as described previously [18].
2.7. Epitope Mapping Studies
For selected proteins, an approximate epitope was determined by cloning and expressing
segments of the protein, in other cases, an overlapping peptide library was synthesized and used
to determine the epitope location. Peptide libraries were constructed (Thermo Scientific) for 2 Map
proteins, MAP_2698c, and MAP_3404. The peptide lengths, sequences, location within each array,
and degree of amino acid overlap are indicated in supplemental Table S2. The design strategies resulted
in 86 total peptides for the MAP_3404 array and 52 total peptides for the MAP_2698c array. Each array
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also included the full length maltose binding protein (MBP) fusion protein as a positive control. Each
peptide was dissolved in distilled water to yield a concentration of between 1 and 1.5 mg/mL and
stored in ultra-low attachment polystyrene 96-well plates (Corning, Kennebunk, ME, USA) at −20 ◦C
with a working stock stored at 4 ◦C. Peptides that were less soluble were gently heated (45 ◦C for
10 min) to hasten dissolving. For crude epitope mapping experiments, cloning and expression of
truncated MBP fusion proteins was performed as described previously [14].
Peptides used for dot blot arrays were spotted onto nitrocellulose sheets using the Bio-dot
apparatus as described above for constructing the protein arrays. These nitrocellulose peptide arrays
were blocked and processed in the same manner as described for immunoblots. For ELISA assays,
peptides were coated onto ELISA plates and processed as described in Section 2.5.
3. Results
3.1. Monoclonal Antibodies to Map Proteins
Collectively, our laboratory has produced a total of 36 mAbs against Map. Of these, ten were
previously produced using a whole cell extract of Map as the immunizing antigen [4]. Another 22 mAbs
were recently generated against Map extracts and characterized in this study. And finally, four mAbs
were generated by immunizing mice with recombinant proteins to MAP_1272 [6] and MAP_2121c [8].
All 36 antibodies were characterized by their reactivity with a panel of 15 mycobacteria representing the
M. avium and M. tuberculosis complexes, as well as fast growing mycobacteria (supplemental Table S3).
Only one mAb was specific for the paratuberculosis subspecies of M. avium (17A12), which has also
been confirmed previously [5]. In contrast, mAb 4B6 binds to a highly conserved protein present
in all mycobacterial species tested (Table S3). The rest of the antibodies showed varying degrees of
cross-reactivity that resembled genetic similarity across the mycobacteria. For example, 88–100% of all
antibodies reacted to all three Map strains tested, whereas only 6% of all antibodies reacted to the more
distantly related M. smegmatis (Table S3).
The cognate antigens for most of these mAbs is unknown despite previous work screening a Map
ATCC19698-lambda expression library [4]. The mAbs in that study could not be identified from the
same expression library despite repeated efforts. Therefore, different approaches were used to identify
the corresponding antigens for several mAbs.
3.2. Monoclonal Antibody Screening Using the Sheep S397 Expression Library
Because 12C9, 14D4, and 14G11 did not yield positive plaques from screening a Map bovine strain
(ATCC19698) expression library [4], a second genomic DNA expression library was cloned from the
Map ovine isolate S397 [19] and screened with the three combined mAbs. Obtained from this screen
were three positive reacting plaques and the inserts from these plaques were subcloned and sequenced
(Figure 1A). Two of the phage clones had inserts containing the same start and stop coordinates and
was 4980 bp in length while phage clone #3 had beginning and ending coordinates within the first two
phage clones and totaled 2943 bp (Figure 1A). All clones overlapped with a region encompassing two
coding sequences (MAP_3976 and MAP_3977c) in the K-10 genome. When the phage clone #3 insert
was subcloned into E. coli and induced to express the insert, only mAb 14G11 reacted with a protein
around 50 kDa in size (Figure 1B). The calculated molecular weight for MAP_3976 is 47 kilodaltons
(kDa), while MAP_3977c is only 26 kDa. Furthermore, the direction of transcription of the lacZ
promoter within the lambda phage clones is indicated by the arrows in Figure 1A and is in frame
with MAP_3976 but on the opposite strand for MAP_3977c. These observations combined to suggest
that the MAP_3976 expression product reacts with mAb 14G11. To confirm this, both genes were
cloned and expressed in E. coli separately. Only MAP_3976 reacted with 14G11 when the purified
recombinant proteins were analyzed by immunoblot analysis (Figure 1C). This protein is a lipoprotein
anchoring transpeptidase.
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Figure 1. Antibody 14G11 reacts with MAP_3976. A genomic expression library screen identified three
phage plaques that reacted to a cocktail of 3 monoclonal antibodies (mAbs). Sequence alignments for
the lambda clone inserts are shown to scale in (a) along with coding sequences from the Mycobacterium
avium subspecies paratuberculosis (Map) K-10 genome present within the smallest insert of phage clone
#3. The scale is shown in base pairs. Phage clone #3 was analyzed by immunoblot under IPTG inducing
and non-inducing conditions as indicated by a “+” or “−“ above each immunoblot in (b) and three
identical immunoblots were exposed to the three mAbs used in the original library screen and indicated
above each blot. Protein size markers (M) are indicated in the left and right margins in kilodaltons.
Only mAb 14G11 reacted to an IPTG induced 50-kDa protein expressed from clone #3 (left blot in (b)).
(c) MAP_3976 and MAP_3977c were cloned and expressed as maltose binding protein (MBP) fusions
and immunoblot analysis confirmed that only MAP_3976 reacted to 14G11 (left blot) while both fusion
proteins reacted to the MBP tag (right blot).
A set of 22 additional mAbs were screened using the original ATCC19698 and the newly
constructed S397 phage libraries. Among these antibodies, 12 reacted with at least 1 plaque from either
library. Three antibodies (1C8, 8C6, and 10D2) bound to the isocitrate lyase protein (MAP_1643), adding
to two mAbs (9G10 and 11F6) that had been obtained in a previous study [4]. Five antibodies bound
to acetyl-CoA carboxylase (MAP_3404), three mAbs bound to the chaperone GroEL2 (MAP_3936),
and one mAb reacted to an electron transfer protein (MAP_3060c) (supplemental Figures S1 and S2).
However, no positive lambda plaques were obtained that had reactivity with two mAbs, 12C9 and
14D4, from our initial study [4]. Therefore, different approaches were needed to identify their respective
binding antigens.
3.3. Dot Blot Array Identifies the Cognate Antigen of mAb 14D4
One characteristic that links the unknown antigens that bind mAbs 12C9 and 14D4 is their similar
molecular size based on migration in SDS-PAGE gels. Their estimated size is 30 to 35 kDa based
on similarity to the known 33.5-kDa major membrane protein (Figure 2a) and comparison with two
commercially available protein marker sets. This size criterion was used to screen recombinant Map
proteins available from our collection [14]. There are 1,988 annotated proteins with calculated molecular
sizes between 20–41 kDa [20]. Our collection had 355 purified Map recombinant proteins available
within this size range, which represents 18% of all Map proteins in that range. These recombinant
proteins were arranged in a dot blot protein array format and exposed to mAbs 14D4 and 12C9
(Figure 2b). Data show that the mAb mixture reacted strongly to three spots on the array, two of
which included the whole cell extract of strain K-10 which served as the positive control (spots D1 and
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H12 in Figure 2b). The recombinant proteins present in spot H2 included MAP_0966c, MAP_2698c,
and MAP_3943. When the proteins and mAbs were separated out and analyzed individually by
denaturing immunoblot, reactivity disappeared (Figure 2c). Subsequent experiments demonstrated
that MAP_2698c is detected by the 14D4 antibody and that only the native form of the protein is
recognized by the antibody (Figure 2d). To determine if the epitope could be located, a MAP_2698c
peptide array was constructed (supplemental Table S2). However, mAb 14D4 appears to bind a
conformational epitope since it did not bind to the MAP_2698c peptide array (data not shown) and
does not react in denaturing Western blot assays (Figure 2c). MAP_2698c is an acyl carrier protein
desaturase that may be involved in mycolic acid biosynthesis and has recently been shown to be
antigenic and located in the cell envelop [21].
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Figure 2. MAP_2698c reacts with mAb 14D4 through a conformation epitope. (a) Immunoblot analysis
with mAbs 14D4 and 12C9 on the whole cell extract of Map K-10 shows the similar molecular sizes
of each protein. These are compared to the 8G2 mAb that binds to the major membrane protein
(MAP_2121c, [8]), which has a calculated molecular weight of 33.6 kDa. (b) Dot blot array containing
355 spotted recombinant proteins (see supplemental Table S1 for spot assignments) was exposed to
12C9 and 14D4. While spots D1 and H12 contain positive controls, spot H2 contains a mixture of
recombinant proteins MAP_0966c, MAP_2698c and MAP_3943. (c) Three identical immunoblots of
each recombinant protein are exposed to mAbs indicated beneath each blot. MAbs 14D4 and 12C9
show no reactivity to any proteins while the α-MBP control, which binds to the affinity tag, shows
proteins are heavily loaded and immunoreactive. (d) Dot blot analysis demonstrates that 14D4 reacts
with the recombinant MAP_2698c, but only under native conditions. The native protein from the K-10
extract is not subject to this limitation. Kilodalton molecular size markers are indicated in (a,c).
3.4. Identification of the 12C9 Binding Antigen by Mass Spectrometry
The 12C9 mAb could not be identified by either a phage library screen or using the dot blot
array of size-selected proteins, yet hybridoma cells strongly secrete this antibody and immunoblot
analysis suggests it binds to a protein approximately 30 kDa (Figure 2a) with strong affinity. Therefore,
the 12C9 antibody was used to capture and enrich for its binding partner via immunoprecipitation
with magnetic beads. Both a direct and indirect capture was conducted (Figure 3a); however, the direct
method captured more antigen (Figure 3b and supplemental Figure S3). The captured eluate was
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resolved on an SDS-PAGE stained gel. A very faint band migrating around 25 kDa was excised from
the polyacrylamide gel and analyzed by mass spectrometry. A total of six proteins were identified from
the 12C9 capture and six proteins from the MBP tag control capture (Table 1). The major component of
the 12C9-captured sample was MAP_4145 with 24 peptides mapping to this protein, three of them
unique (Table 1). BLAST analysis suggested the gene product is a membrane protein, however, PSORTb
3.0 analysis [22] could not predict a definitive location, even though two internal alpha helices were
found. Nonetheless, our previous analysis with 12C9 on membrane- and cytosol-enriched Map extracts
demonstrated that the protein is present primarily in membrane extracts [4].
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Figure 3. Direct and indirect capture of the Map antigen that binds mAb 12C9. Shown is a schematic
flow diagram of the two methods (a). The primary difference between these methods is that the
mAb is bound to the magnetic beads before exposure to the antigen extract versus afterwards as
in the indirect method. The brown sphere is the magnetic bead. Both methods were analyzed by
SDS-PAGE and immunoblot analysis (b). Shown are stained sodium dodecyl sulfate–polyacrylamide
gel electrophoresis (SDS-PAGE) gels (top) and corresponding immunoblots probed with 12C9 (bottom)
for the direct (left) and indirect (right) capture experiments. The 12C9 probed blots show that the
antigen was captured while the anti-mouse control had no reactivity suggesting that the capture was
specific. Lanes for the direct method are: 1 = Protein size markers, 2 = bead coupled 12C9 antibody,
3 = K-10 antigen before capture, 4 = K-10 antigen after capture with 12C9 magnetic beads, 5 = combined
washes, and 6 = antigen eluted from magnetic beads. Lanes for the indirect method are: 1 and
2 = Protein size standards, 3 = K-10 antigen mixed with 12C9 antibody, 4 = combined washes after
incubation, and 5 = antigen eluted from magnetic beads.
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Table 1. Mass spectrometry results.
Identified Proteins Accession Number Weight Locus Tag
Total Read Counts No. of Unique Peptides
MBP 12C9 MBP 12C9
Uncharacterized protein M. paratuberculosis (strain ATCC BAA-968/K-10) GN=MAP_4145 PE = 4 SV = 1 Q73SC9_MYCPA 30 kDa MAP_4145 0 24 3
60 kDa chaperonin 2 M. paratuberculosis (strain ATCC BAA-968/K-10) GN=groL2 PE = 3 SV = 4 CH602_MYCPA 57 kDa MAP_3936 10 0 3
Uncharacterized oxidoreductase MAP_3007 M. paratuberculosis (strain ATCC BAA-968/K-10) GN=MAP_3007
PE = 3 SV = 1 Y3007_MYCPA 30 kDa MAP_3007 12 0 4
35kd_ag M. paratuberculosis (strain ATCC BAA-968/K-10) GN=MAP_2855c PE = 4 SV = 1 Q73W06_MYCPA 29 kDa MAP_2855c 0 4 2
Uncharacterized protein M. paratuberculosis (strain ATCC BAA-968/K-10) GN=MAP_2720c PE = 4 SV = 1 Q73WE0_MYCPA 33 kDa MAP_2720c 0 4 2
Haloalkane dehalogenase M. paratuberculosis (strain ATCC BAA-968/K-10) GN=dhmA PE = 3 SV = 1 DHMA_MYCPA 34 kDa MAP_2057c 0 4 2
Wag31 M. paratuberculosis (strain ATCC BAA-968/K-10) GN=wag31 PE = 4 SV = 1 Q73YR6_MYCPA 28 kDa MAP_1889c 6 0 2
Malate dehydrogenase M. paratuberculosis (strain ATCC BAA-968/K-10) GN=mdh PE = 3 SV = 1 MDH_MYCPA 35 kDa MAP_2541c 0 4 2
Uncharacterized protein M. paratuberculosis (strain ATCC BAA-968/K-10) GN=MAP_0398c PE = 4 SV = 1 Q744E3_MYCPA 25 kDa MAP_0398c 0 4 2
Ornithine carbamoyltransferase M. paratuberculosis (strain ATCC BAA-968/K-10) GN=argF PE = 3 SV = 1 OTC_MYCPA 34 kDa MAP_1365 6 0 3
Pyrroline-5-carboxylate reductase M. paratuberculosis (strain ATCC BAA-968/K-10) GN=proC PE = 3 SV = 1 Q73ST2_MYCPA 30 kDa MAP_3991 4 0 2
Hsp90 co-chaperone Cdc37 OS=Bos taurus GN=CDC37 PE = 2 SV = 1 CDC37_BOVIN (+1) 45 kDa 4 0 2
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To confirm the results of the immuno-capture and tandem mass spectrometry analysis, the gene
must be cloned and expressed and tested with 12C9. However, this gene resisted amplification in all
conditions tested due to the unusually high G + C content in the open reading frame. Specifically,
there is a region of 150 base pairs starting at nucleotide 609 that has a G + C content of 85.3% (Figure 4a),
which resulted in a melting temperature above 80 ◦C. To overcome this obstacle, the complete 849-bp
gene was codon optimized, synthesized and cloned into an E. coli expression vector. The codon
optimized MAP_4145 effectively lowered the G + C content of the 150-bp region from 85.3% to
72.7% (Figure 4b). The expressed protein was immunoblotted and confirmed that 12C9 does react to
MAP_4145 (Figure 4c).
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within the bacterial cell and determine their presence in defined fractions of Map. 
3.5. Epitope Mapping of Selected mAbs to Map Proteins 
Multiple mAbs to MAP_3936 and MAP_3404 were obtained in this study. Therefore, the 
epitopes were identified to determine if single or multiple epitopes were recognized in each protein. 
Of the three mAbs to groEL2 encoded by MAP_3936, two react to epitopes near the center of the 
protein (10C12 and 11F8), while 7A6 binds between amino acid 408 and 541 at the C-terminal end 
based on reactivity to truncated fragments of the protein (supplemental Figure S4). An overlapping 
Figure 4. Codon optimized MAP_4145 reacts with mAb 12C9. The native (a) and codon optimized
(b) percent G-C plots show the effect of replacing guanine or cytosine nucleotides with adenine and
thymine at redundant locations. The brackets identify a 150 bp region that is especially rich in GC
content. (c) SDS-PAGE and corresponding immunoblot shows that 12C9 reacts specifically and strongly
to the codon optimized MAP_4145. Lanes: 1 = protein size markers, 2 = MAP_1609c, 3 = MAP_3842,
and 4 = codon optimized MAP_4145.
The binding targets for many of these Map mAbs have now been identified. This new information,
combined with those from our earlier studies, are summarized in Table 2. This represents the most
complete catalog of monoclonal antibodies to Map proteins available for research studies. With this
new information, we can uniquely examine these proteins for relative abundance within the bacterial
cell and determine their presence in defined fractions of Map.
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Table 2. Antibodies and corresponding antigen characteristics.
mAb mAb Cognate Antigen Antigen
Reference
Name Isotype a Antigen Epitope Location Antigen Description Size (kDa) Location b
17A12-3B10 c IgG1 MAP_1025 28-HPGGQQP-34 Proline rich antigen (Pra); RDD family protein 25.0 Cytoplasmic membrane Bannantine et al. [5]
14C5 d IgG2a MAP_1272c Between amino acids 26 and 74 NlpC/P60 domain protein; peptidoglycan hydrolase 29.2 Cytoplasmic membrane Bannantine et al. [19]
8G6 d IgG1 MAP_1272c Between amino acids 74 and 128 NlpC/P60 domain protein; peptidoglycan hydrolase 29.2 Cytoplasmic membrane Bannantine et al. [19]
9G10 IgG2a MAP_1643 C-terminal half of protein isocitrate lyase, AceAb 85.2 Cytoplasmic Bannantine et al. [4]
11F6 IgG1 MAP_1643 C-terminal half of protein isocitrate lyase, AceAb 85.2 Cytoplasmic Bannantine et al. [4]
8C6 ND MAP_1643 isocitrate lyase, AceAb 85.2 Cytoplasmic This study e
10D2 IgG2b MAP_1643 isocitrate lyase, AceAb 85.2 Cytoplasmic This study
1C8 ND f MAP_1643 isocitrate lyase, AceAb 85.2 Cytoplasmic This study
13E1-4E3 g IgG1 MAP_2121c Binds only to full length protein Major membrane protein (MMP) 33.6 Cytoplasmic membrane Bannantine et al. [8]
8G2-2A10 g IgG1 MAP_2121c Between amino acids 78 and 153 Major membrane protein (MMP) 33.6 Cytoplasmic membrane Bannantine et al. [8]
14G3 IgG2a Unknown ~40 Bannantine et al. [4]
14D4 IgG3 MAP_2698c Conformational epitope f Fatty acid desaturase 31.5 Unknown h Bannantine et al. [4]
6C9 IgG1 MAP_3060c Electron transfer protein, a-subunit 32.0 Cytoplasmic This study
3G5 No react i MAP_3404 Acetyl-CoA carboxylase, biotin carboxylase subunit 64.3 Cytoplasmic This study
7C8 IgG2a MAP_3404 Acetyl-CoA carboxylase, biotin carboxylase subunit 64.3 Cytoplasmic This study
9H3 IgG2b MAP_3404 316-TEETAGIDLVLQQFK-330 Acetyl-CoA carboxylase, biotin carboxylase subunit 64.3 Cytoplasmic This study
12E4 IgG1 MAP_3404 Acetyl-CoA carboxylase, biotin carboxylase subunit 64.3 Cytoplasmic This study
11B8 IgG1 MAP_3404 470-PFTGGEPL-477 Acetyl-CoA carboxylase, biotin carboxylase subunit 64.3 Cytoplasmic This study
11G4 IgG1 MAP_3840 N-terminal half of protein DnaK chaperone; Heat shock protein 66.5 Cytoplasmic Bannantine et al. [4]
13A4 IgG2b MAP_3840 Binds only to full length protein DnaK chaperone; Heat shock protein 66.5 Cytoplasmic Bannantine et al. [4]
7A6 IgG2a MAP_3936 Molecular chaperone GroEL2 56.6 Cytoplasmic This study
11F8 IgG2b MAP_3936 Molecular chaperone GroEL2 56.6 Cytoplasmic This study
10C12 IgG1 MAP_3936 Molecular chaperone GroEL2 56.6 Cytoplasmic This study
14G11 IgG1 MAP_3976 Not determined Lipoprotein anchoring transpeptidase 47.0 Cytoplasmic membrane Bannantine et al. [4]
12C9 IgG1 MAP_4145 Between amino acids 71 and 212 Membrane protein with a short C-terminal domain 30.0 Cytoplasmic membrane Bannantine et al. [4]
4B6 IgG1 Unknown Unknown A highly conserved, unidentified mycobacterial protein ~42 Cytoplasmic Bannantine et al. [4]
12F9 IgG1 Unknown This study
5E6 IgG1 Unknown This study
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Table 2. Cont.
mAb mAb Cognate Antigen Antigen
Reference
Name Isotype a Antigen Epitope Location Antigen Description Size (kDa) Location b
10D4 IgG1 Unknown This study
11F9 IgG1 Unknown This study
13G7 ND f Unknown This study
2D12 IgG1 Unknown This study
1F2 IgG2a Unknown This study
4A9 IgG1 Unknown This study
4G1 IgM Unknown This study
11F5 ND Unknown Binds to a protein of similar size to MAP_3404 ~65 This study
a Only the heavy chain isotype is indicated. All antibodies listed here have the kappa light chain. b Antigen location was based on either PSORTb 3.0 results or immunoblot results against
membrane- and cytoplasmic-enriched protein preps, or both. c mAb 17A12 was obtained using a membrane enriched extract as the immunizing antigen. d mAbs 14C5, 8G6 were obtained
using recombinant MAP_1272c as the immunizing antigen. e This study means the antibody has not been published prior to this article. f No reactivity observed on a peptide array of
MAP2698c except the full-length protein, suggesting a conformational epitope. g mAbs 13E1-4E3 and 8G2-2A10 were obtained using recombinant MAP_2121c at the immunizing antigen.
h The PSORTb 3.0 prediction for MAP_2698c is unknown; however, the literature suggests it is in the membrane (He and DeBuck 2012) i No react = No reaction to isotyping antibodies.
Was repeated three times.
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3.5. Epitope Mapping of Selected mAbs to Map Proteins
Multiple mAbs to MAP_3936 and MAP_3404 were obtained in this study. Therefore, the epitopes
were identified to determine if single or multiple epitopes were recognized in each protein. Of the
three mAbs to groEL2 encoded by MAP_3936, two react to epitopes near the center of the protein
(10C12 and 11F8), while 7A6 binds between amino acid 408 and 541 at the C-terminal end based on
reactivity to truncated fragments of the protein (supplemental Figure S4). An overlapping peptide
array (supplemental Table S1) was used to identify epitopes to the five MAP_3404 mAbs. Using this
array, the 11B8 epitope was defined to eight amino acids (Figure 5). The other four antibodies had
complex reactivity patterns that were difficult to determine the precise epitopes, but the reactivity
patterns were similar enough that it appears likely to be a similar epitope shared among them
(supplemental Figure S5).
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Figure 5. The epitope for 11B8 is defined to eight amino acids. An overlapping peptide library was
spotted onto nitrocellulose and exposed to 11B8 (a). In addition to the native protein spotted in H5 and
H7, the antibody reacts to overlapping peptides spotted in F7 and F8. The 15-amino acid peptides in
F7 and F8 are shown (b) along with the overla ping amino acids highlighted in red. The consensus
epitope is shown at the bottom and occurs at 470 to 477 in MAP_3404.
The 12C9 epitope was mapped to the center region of the MAP_4145 protein. Portions of the
MAP_4145 were cloned such th t the N-terminal, C-t rminal, and center sections of the p otein were
independently express . Only the center 142 amino acids from 71 to 212 was detected by the antibody
(supplementa Figure S6).
3.6. Monoclonal Antibody Use in Mycobacterial Proteomics
With the antigen identity known for many of the mAbs from this and other studies, they can
now be used in many applications. One application is to quickly test the quality and relative
abundance of selected proteins in fractionated proteomic preparations. As an example, several
mycobacterial sonicated preparations were analyzed for relative abundance of protein in denaturing
and non-denaturing conditions (Figure 6). There is a striking change in relative abundance of proteins
from strain to strain in the two conditions. It is important to note that the lower abundance in
the denatured condition for isocitrate lyase (MAP_1643) and lipoprotein anchoring transpeptidase
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(MAP_3976) is more likely due to heat susceptibility of the epitope rather than a change of abundance.
The epitope to the proline rich antigen (MAP_1025) was less affected, but still showed a slight decrease
in reactivity in the denatured condition. The opposite is observed for the MAP_4145 protein. There is
a slight increase in the reactivity when the protein is denatured compared to native. The epitope in
MAP_1025 is specific for only the paratuberculosis subspecies, even though the protein itself is present
in other MAC complex strains [5], yet abundance similarities exist between the ileum Map isolate
and the K-10 strain. Likewise, the levels are similar between the sheep strain and bovine isolate 6012.
MAP_4145 and MAP_1025 protein levels are essentially identical in K-10 and present in higher relative
abundance than is the transpeptidase (MAP_3976).
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Figure 6. Relative abundance of select Map proteins in whole cell extracts of mycobacteria. Shown are
a series of identically loaded dot blots with dilutions indicated in the left margin and MAC complex
strain indicated beneath each blot. The protein detected and condition tested are shown above each blot.
Note that relative abundance of each protein can be determined across each prep and between preps.
4. Discussion
Antibodies are powerful tools in diagnostic and molecular immunology studies. However, their
utility is limited if their corresponding antigen is unknown. A recent application of Map monoclonal
antibodies is for immunomagnetic separation; however, no effort was made to identify their binding
partners [2]. In additio , Abs that bind to lipoarabi mannan (LAM) in the m cobacterial cell
wall were used to i entify tu erculosis-infected patients usi g an electrochemiluminescence assay
on urine amples [23]. The best captur an det ction mAb pairs were identified from a collection
of anti-LAM mAbs and used to greatly incr ase the sensitiv ty and specificity in a point-of-care test
for tuberculosis. A similar capture mAb-detection mAb approach could be applied o John ’s disease
diagnosis using the Abs described herein. In this study, we identified the corresp nding antigens for
all of the monoclonal antibodies described in our earlier study [4] as well as many from the current
study. The co plete list of Map monoclonal antibodies and their corresponding antigens is listed in
Table 2.
While several of the mAbs were identified by screening a phage expression library, others could
not be identified by this approach despite repeated efforts using two independent phage libraries.
This suggests the biased nature of the library construction. If restriction sites used in library cloning do
not result in in-frame expression clones then E. coli will not express the protein and thus the antigen
cannot be identified. The protein array is an unbiased approach, but getting a complete array is not
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trivial. The antigen to 12C9 could not be identified despite using molecular approaches including
protein array analysis and screening phage expression libraries, all of which had proven unsuccessful.
Only through biochemical and immunological approaches that include affinity purification and
immunoprecipitation was the 12C9 binding antigen identified.
It is well-known that E. coli does not tolerate heterologous membrane protein expression [24]
and this might partially explain why more antigens were not identified by this screening method.
Another possibility is that the phage library was not fully representative and thus did not contain
every expressed gene. Besides underrepresentation, phage expression library approaches have a few
pitfalls to be aware of. The expression library artificially forces expression of any cloned segment,
regardless of whether or not the sequence codes for a real protein. Thus mimotopes, which mimic a
real epitope, can be present in these libraries leading the researcher on a “wild goose chase”. In one
such case, our group identified the one antibody (17A12) that is truly specific to Map and does not
cross-react with other closely related M. avium subspecies [5]. However, when screening a phage
expression library to identify the corresponding protein, a mimotope present in an unannotated region
of the Map genome was obtained from four independent, positive library clones. Only after defining
the mimotope down to seven amino acids were we able to use that information to screen the Map
genome to identify the real epitope which had a one amino acid difference from the mimotope [5].
Another pitfall appears when the expression library was constructed for an organism that does
not actually produce the epitope. This happened when a group was attempting to identify a protein
associated with gastric cancer development [11]. They thought that the antigen was produced in a
human gastric cell line (MGC0803) since mice that were immunized with MGC0803 yielded a mAb
that would specifically react with tumor cells. However, the library screen failed and the subsequent
immunocapture experiment identified the antigen which was actually produced by Mycoplasma [11].
In the current study, 11 mAbs all bound to annotated proteins in the expression library and could
easily be confirmed by testing corresponding recombinant proteins.
Likely the reason why MAP_4145 was never identified from either DNA expression library is
because of the very high GC content in that gene. All attempts to amplify and clone MAP_4145 failed
until it was codon optimized to lower the GC content. Once this was accomplished, the amplification,
cloning, and expression in E. coli were easily obtained. Because of this difficulty in heterologous
expression of MAP_4145, immunomagnetic precipitation was the only method to successfully capture
and identify this protein.
Mapping of the fatty acid desaturase (MAP_2698c) epitope using an overlapping peptide array
approach did not work. Furthermore, the native protein was not susceptible to heat denaturation
while the full-length recombinant was susceptible. The reasons for this differential reactivity could be
further defined, but our results strongly suggest this antibody recognizes a conformational epitope.
With these mAb binding partners known, the locations of the antigens within the bacilli that were
determined experimentally can now be compared with bioinformatic protein location predictions such
as PSORTb analysis. The mAbs 12C9 and 14G11 both bound to antigens present in membrane-enriched
fractions of Map [4] while their corresponding antigens MAP_4145 and MAP_3976 were predicted to
be membrane located by PSORTb analysis [22] in this study (Table 2). For the desaturase (MAP_2698c)
protein, PSORTb could not predict its location, however, experimental evidence clearly suggests
this protein is in the membrane [4,25]. Conversely, 9G10 and 11G4 clearly bound to isocitrate lyase
and DnaK, two proteins in the cytoplasm [4], and PSORTb correctly predicted that location as well.
This demonstrates that PSORTb is an accurate predictor of protein location within bacteria.
Antibodies were used to determine abundance in whole cell extracts of mycobacteria belonging to
the MAC complex. This can be readily applied to any fractionated protein preparation. Researchers can
quickly determine presence or absence of specific proteins and examine how each protein’s abundance
changes in different conditions and strains.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/6/4/127/s1,
Figure S1: mAbs 11F8, 7A6 and 10C12 react to the MAP_3936 coding sequence within phage clone #4-2a, Figure S2:
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mAb 6C9 binds to MAP_3060c, Figure S3: The antigen that binds 12C9 was captured in a specific manner, Figure S4:
Location of antibody epitopes to the MAP_3936 groEL2 protein, Figure S5: MAP_3404 epitope mapping using an
overlapping peptide array, Figure S6: Location of the 12C9 antibody epitope to the center region of MAP_4145,
Table S1: Recombinant protein assignments on the dot blot array shown in Figure 2B, Table S2: Peptide library
sequences and spot/well locations for MAP_2698c and MAP_3404, Table S3: Monoclonal antibody reactivity to
mycobacterial species.
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